Sarah Temkin, MD, associate director for clinical research in the Office of Research on Women’s Health (ORWH) at the National Institutes of Health (NIH), discusses how the work of the NIH ORWH impacts pharmacy practice.
Pharmacy Times interviewed Sarah Temkin, MD, associate director for clinical research in the Office of Research on Women’s Health (ORWH) at the National Institutes of Health (NIH). Temkin was recently a keynote speaker at the Sex and Gender Health Education Summit, which looked to address the current progress to transform medical education and health care training.
Sarah Temkin: So, at the [ORWH], we primarily work collaboratively with the NIH's 27 institutes and centers to ensure that women's health research is part of the scientific framework of the [NIH] and throughout the entire scientific community.
Our commitment is to enhance basic pre-clinical and clinical foundations of women's health research such that all women can receive evidence-based and high-quality care for all their health care needs.
One thing that I think the [ORWH] does that I just wanted to mention is that we host several interprofessional education courses that are online and freely available for any health care professional to utilize that really explain some of the foundations of inclusion of sex and gender into research related to health; those include the bench to bedside course that integrate science sex and gender into improved human health, the sex as a biologic variable primer, and an introduction to the scientific basis of sex and gender-related differences.